FT: Cracking cancer: A $1tn race for treatments is excluding some forms of the disease (Part 1)

This Financial Times series delves into the renewed vigor in the fight against cancer, highlighting breakthroughs in treatments for aggressive cancers like breast, lung, and prostate. However, the battle against pancreatic cancer lags, with outdated treatments and underfunded research. Despite these challenges, emerging innovations, including new immunotherapies and potential vaccines, offer hope for tackling the deadliest cancers. The series explores how funding and focus could reshape cancer care in the future.

Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.

By Oliver Barnes in New York and Ian Johnston in London

The first in an FT series looking at the new energy behind the fight for cancer cures

___STEADY_PAYWALL___